1. Abujiang, P, Mori, TJ, Takahashi, T, Tanaka, F, Kasyu, I, Hitomi, S & Hiai, H (1998). Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers. Oncogene 17: 3029–3033.
2. Balsara, BR, Bell, DW, Sonoda, G, De Rienzo, A, du Manoir, S, Jhanwar, SC & Testa, JR (1999). Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1–15 in human malignant mesothelioma. Cancer Res 59: 450–454.
3. Bandera, CA, Takahashi, H, Behbakht, K, Liu, PC, LiVolsi, VA, Benjamin, I, Morgan, MA, King, SA, Rubin, SC & Boyd, J (1997). Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma. Cancer Res 57: 513–515.
4. Bell, DW, Jhanwar, SC & Testa, JR (1997). Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Res 57: 4057–4062.
5. Bianchi, AB, Mitsunaga, S-I, Cheng, JQ, Klein, WM, Jhanwar, SC, Seizinger, B, Kley, N, Klein-Szanto, AJP & Testa, JR (1995). High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesothelioma. Proc Natl Acad Sci USA 92: 10854–10858.